Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Nano Today. 2018 Mar 10;19:188–200. doi: 10.1016/j.nantod.2018.02.011

Figure 4.

Figure 4

Measurement of CAC by fluorescence properties of pyrene upon inclusion into colloidal drug aggregates of ritonavir. The onset of aggregation corresponds to the decrease in I1/I3 fluorescence ratio as the pyrene enters a more hydrophobic environment. Reprinted with permission from Ref. [15]. Copyright 2013 American Chemical Society.